Literature DB >> 19066935

Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle's disease.

Graham J Kemp1, Caterina Tonon, Emil Malucelli, Claudia Testa, Alexandra Liava, David Manners, Enrico Trevisi, Andrea Martinuzzi, Bruno Barbiroli, Raffaele Lodi.   

Abstract

Cellular pH control is important in muscle physiology, and for interpretation of (31)P magnetic resonance spectroscopy (MRS) data. Cellular acidification in exercise results from coupled glycolytic ATP production mitigated by cytosolic buffering, 'consumption' of H(+) by phosphocreatine (PCr) breakdown, and membrane transport processes. Ex vivo methods for cytosolic buffer capacity are vulnerable to artefact, and MRS methods often require assumptions. (31)P MRS of early exercise, when pH increases unopposed by glycolysis, is conceptually simple, but limited in normal muscle by time resolution and signal-to-noise. A therapeutic trial (Martinuzzi A et al. Musc Nerve 37: 350-357, 2007) in McArdle's disease (glycogen phosphorylase deficiency), where pH does not decrease with exercise, offered the opportunity to test (31)P MRS data obtained throughout incremental plantar flexion exercise and recovery in ten McArdle's patients against the simple model of cellular pH control. Changes in pH, [Pi] and [PCr] throughout exercise and recovery were quantitatively consistent with mean +/- SEM buffer capacity of 10 +/- 1 mM/(pH unit), which was not significantly different from the control subjects under the initial-exercise conditions where the comparison could be made. The simple model of cellular acid-base balance therefore gives an adequate account of cellular pH changes during both exercise and recovery in McArdle's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066935     DOI: 10.1007/s00421-008-0950-0

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  24 in total

1.  Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy.

Authors:  G J Kemp; M Roussel; D Bendahan; Y Le Fur; P J Cozzone
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

Review 2.  Applying physicochemical principles to skeletal muscle acid-base status.

Authors:  Michael I Lindinger; John M Kowalchuk; George J F Heigenhauser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09       Impact factor: 3.619

3.  Explaining pH change in exercising muscle: lactic acid, proton consumption, and buffering vs. strong ion difference.

Authors:  Graham Kemp; Dieter Böning; Ralph Beneke; Norbert Maassen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-07       Impact factor: 3.619

Review 4.  Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.

Authors:  Graham J Kemp; Martin Meyerspeer; Ewald Moser
Journal:  NMR Biomed       Date:  2007-10       Impact factor: 4.044

5.  pH-Dependence of extrinsic and intrinsic H(+)-ion mobility in the rat ventricular myocyte, investigated using flash photolysis of a caged-H(+) compound.

Authors:  Pawel Swietach; Kenneth W Spitzer; Richard D Vaughan-Jones
Journal:  Biophys J       Date:  2006-10-20       Impact factor: 4.033

6.  Muscle buffer capacity estimated from pH changes during rest-to-work transitions.

Authors:  G R Adams; J M Foley; R A Meyer
Journal:  J Appl Physiol (1985)       Date:  1990-09

7.  Linear dependence of muscle phosphocreatine kinetics on oxidative capacity.

Authors:  A T Paganini; J M Foley; R A Meyer
Journal:  Am J Physiol       Date:  1997-02

8.  Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease.

Authors:  Andrea Martinuzzi; Alexandra Liava; Enrico Trevisi; Mara Frare; Caterina Tonon; Emil Malucelli; David Manners; Graham J Kemp; Claudia Testa; Bruno Barbiroli; Raffaele Lodi
Journal:  Muscle Nerve       Date:  2008-03       Impact factor: 3.217

9.  pH control in rat skeletal muscle during exercise, recovery from exercise, and acute respiratory acidosis.

Authors:  G J Kemp; C H Thompson; A L Sanderson; G K Radda
Journal:  Magn Reson Med       Date:  1994-02       Impact factor: 4.668

10.  Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy.

Authors:  Martin Meyerspeer; Graham J Kemp; Vladimir Mlynárik; Martin Krssák; Julia Szendroedi; Peter Nowotny; Michael Roden; Ewald Moser
Journal:  Magn Reson Med       Date:  2007-04       Impact factor: 4.668

View more
  3 in total

Review 1.  In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.

Authors:  Ladislav Valkovič; Marek Chmelík; Martin Krššák
Journal:  Anal Biochem       Date:  2017-01-21       Impact factor: 3.365

2.  Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.

Authors:  Gustav J Strijkers; Ericky C A Araujo; Noura Azzabou; David Bendahan; Andrew Blamire; Jedrek Burakiewicz; Pierre G Carlier; Bruce Damon; Xeni Deligianni; Martijn Froeling; Arend Heerschap; Kieren G Hollingsworth; Melissa T Hooijmans; Dimitrios C Karampinos; George Loudos; Guillaume Madelin; Benjamin Marty; Armin M Nagel; Aart J Nederveen; Jules L Nelissen; Francesco Santini; Olivier Scheidegger; Fritz Schick; Christopher Sinclair; Ralph Sinkus; Paulo L de Sousa; Volker Straub; Glenn Walter; Hermien E Kan
Journal:  J Neuromuscul Dis       Date:  2019

3.  31 P magnetic resonance spectroscopy in skeletal muscle: Experts' consensus recommendations.

Authors:  Martin Meyerspeer; Chris Boesch; Donnie Cameron; Monika Dezortová; Sean C Forbes; Arend Heerschap; Jeroen A L Jeneson; Hermien E Kan; Jane Kent; Gwenaël Layec; Jeanine J Prompers; Harmen Reyngoudt; Alison Sleigh; Ladislav Valkovič; Graham J Kemp
Journal:  NMR Biomed       Date:  2020-02-10       Impact factor: 4.044

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.